Synopsys (NASDAQ:SNPS – Get Free Report) issued an update on its FY 2025 earnings guidance on Wednesday morning. The company provided EPS guidance of 14.880-14.960 for the period, compared to the consensus EPS estimate of 14.890. The company issued revenue guidance of $6.7 billion-$6.8 billion, compared to the consensus revenue estimate of $6.8 billion. Synopsys also updated its Q2 2025 guidance to 3.370-3.420 EPS.
Synopsys Stock Up 0.2 %
Synopsys stock traded up $1.07 during mid-day trading on Friday, reaching $455.78. 413,075 shares of the company’s stock were exchanged, compared to its average volume of 1,114,278. Synopsys has a twelve month low of $454.05 and a twelve month high of $624.80. The company has a market cap of $70.45 billion, a P/E ratio of 31.39, a P/E/G ratio of 3.23 and a beta of 1.12. The company has a fifty day moving average of $506.84 and a 200-day moving average of $516.13.
Analysts Set New Price Targets
SNPS has been the subject of several research analyst reports. Morgan Stanley dropped their target price on shares of Synopsys from $625.00 to $590.00 and set an “overweight” rating on the stock in a research report on Monday. Rosenblatt Securities reaffirmed a “buy” rating and issued a $660.00 price target on shares of Synopsys in a report on Tuesday. Robert W. Baird decreased their target price on shares of Synopsys from $644.00 to $630.00 and set an “outperform” rating on the stock in a research report on Thursday, December 5th. Piper Sandler cut their target price on Synopsys from $655.00 to $653.00 and set an “overweight” rating on the stock in a research report on Thursday. Finally, Needham & Company LLC reissued a “buy” rating and issued a $650.00 target price on shares of Synopsys in a research note on Thursday. One investment analyst has rated the stock with a hold rating and twelve have issued a buy rating to the company’s stock. Based on data from MarketBeat, the company has a consensus rating of “Moderate Buy” and an average price target of $638.58.
Insider Transactions at Synopsys
In related news, CRO Richard S. Mahoney sold 20,838 shares of the business’s stock in a transaction on Wednesday, January 15th. The stock was sold at an average price of $506.01, for a total value of $10,544,236.38. Following the sale, the executive now owns 1,460 shares of the company’s stock, valued at $738,774.60. The trade was a 93.45 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. 0.62% of the stock is currently owned by corporate insiders.
Synopsys Company Profile
Synopsys, Inc provides electronic design automation software products used to design and test integrated circuits. It operates in three segments: Design Automation, Design IP, and Software Integrity. The company offers Digital and Custom IC Design solution that provides digital design implementation solutions; Verification solution that offers virtual prototyping, static and formal verification, simulation, emulation, field programmable gate array (FPGA)-based prototyping, and debug solutions; and FPGA design products that are programmed to perform specific functions.
Further Reading
- Five stocks we like better than Synopsys
- What is Put Option Volume?
- 5 Best Gold ETFs for March to Curb Recession Fears
- Buy P&G Now, Before It Sets A New All-Time High
- 3 Stocks for Your Watchlist: Unlocking Tomorrow’s Winners Today
- Where to Find Earnings Call Transcripts
- Why Smart Investors Are Watching These 3 Undervalued Stocks
Receive News & Ratings for Synopsys Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Synopsys and related companies with MarketBeat.com's FREE daily email newsletter.